Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Alzheimer's disease drug development pipeline: 2021
Jeffrey L. Cummings, Garam Lee, Kate Zhong, et al.
Alzheimer s & Dementia Translational Research & Clinical Interventions (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 414

Showing 1-25 of 414 citing articles:

Alzheimer's disease
Philip Scheltens, Bart De Strooper, Miia Kivipelto, et al.
The Lancet (2021) Vol. 397, Iss. 10284, pp. 1577-1590
Open Access | Times Cited: 2963
2022 Alzheimer's disease facts and figures

Alzheimer s & Dementia (2022) Vol. 18, Iss. 4, pp. 700-789
Closed Access | Times Cited: 1940
Alzheimer's disease drug development pipeline: 2022
Jeffrey L. Cummings, Garam Lee, Pouyan Nahed, et al.
Alzheimer s & Dementia Translational Research & Clinical Interventions (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 526
Global estimates on the number of persons across the Alzheimer's disease continuum
Anders Gustavsson, Nicholas Norton, Thomas N. Fast, et al.
Alzheimer s & Dementia (2022) Vol. 19, Iss. 2, pp. 658-670
Open Access | Times Cited: 435
Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association Workgroup
Clifford R. Jack, J. Scott Andrews, Thomas G. Beach, et al.
Alzheimer s & Dementia (2024) Vol. 20, Iss. 8, pp. 5143-5169
Open Access | Times Cited: 426
Alzheimer's disease drug development pipeline: 2023
Jeffrey L. Cummings, Yadi Zhou, Garam Lee, et al.
Alzheimer s & Dementia Translational Research & Clinical Interventions (2023) Vol. 9, Iss. 2
Open Access | Times Cited: 321
Autophagy in Alzheimer’s disease pathogenesis: Therapeutic potential and future perspectives
Zhigang Zhang, Xifei Yang, You‐Qiang Song, et al.
Ageing Research Reviews (2021) Vol. 72, pp. 101464-101464
Open Access | Times Cited: 222
Challenges and hopes for Alzheimer’s disease
Suren A. Tatulian
Drug Discovery Today (2022) Vol. 27, Iss. 4, pp. 1027-1043
Closed Access | Times Cited: 195
Applications of Phyto-Nanotechnology for the Treatment of Neurodegenerative Disorders
Tanima Bhattacharya, Giselle A. Borges e Soares, Hitesh Chopra, et al.
Materials (2022) Vol. 15, Iss. 3, pp. 804-804
Open Access | Times Cited: 188
Lipid metabolism and Alzheimer's disease: clinical evidence, mechanistic link and therapeutic promise
Fei Yin
FEBS Journal (2022) Vol. 290, Iss. 6, pp. 1420-1453
Open Access | Times Cited: 182
Alzheimer’s Disease: An Update and Insights Into Pathophysiology
Murtala Bello Abubakar, Kamaldeen Olalekan Sanusi, Azizah Ugusman, et al.
Frontiers in Aging Neuroscience (2022) Vol. 14
Open Access | Times Cited: 159
Amyloid β, Tau, and α-Synuclein aggregates in the pathogenesis, prognosis, and therapeutics for neurodegenerative diseases
Urmi Sengupta, Rakez Kayed
Progress in Neurobiology (2022) Vol. 214, pp. 102270-102270
Open Access | Times Cited: 156
Dementia prevention in memory clinics: recommendations from the European task force for brain health services
Giovanni B. Frisoni, Daniele Altomare, Federica Ribaldi, et al.
The Lancet Regional Health - Europe (2023) Vol. 26, pp. 100576-100576
Open Access | Times Cited: 113
Alzheimer’s disease: Insights and new prospects in disease pathophysiology, biomarkers and disease-modifying drugs
Ana Rita Monteiro, Daniel José Barbosa, Fernando Remião, et al.
Biochemical Pharmacology (2023) Vol. 211, pp. 115522-115522
Open Access | Times Cited: 112
Small molecules and their impact in drug discovery: A perspective on the occasion of the 125th anniversary of the Bayer Chemical Research Laboratory
Hartmut Beck, Michael Härter, B. Hass, et al.
Drug Discovery Today (2022) Vol. 27, Iss. 6, pp. 1560-1574
Open Access | Times Cited: 107
Designing the next-generation clinical care pathway for Alzheimer’s disease
Harald Hampel, Rhoda Au, Soeren Mattke, et al.
Nature Aging (2022) Vol. 2, Iss. 8, pp. 692-703
Open Access | Times Cited: 107
Glutamate and GABA in Microglia-Neuron Cross-Talk in Alzheimer’s Disease
Grzegorz A. Czapski, Joanna B. Strosznajder
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 21, pp. 11677-11677
Open Access | Times Cited: 106
The role of serotonin within the microbiota-gut-brain axis in the development of Alzheimer’s disease: A narrative review
Emma Aaldijk, Yannick Vermeiren
Ageing Research Reviews (2022) Vol. 75, pp. 101556-101556
Open Access | Times Cited: 90
Detection and Management of Amyloid-Related Imaging Abnormalities in Patients with Alzheimer’s Disease Treated with Anti-Amyloid Beta Therapy
Jerome Barakos, Derk D. Purcell, Joyce Suhy, et al.
The Journal of Prevention of Alzheimer s Disease (2022)
Open Access | Times Cited: 89
Early-stage Alzheimer disease: getting trial-ready
Paul Aisen, Gustavo Jimenez‐Maggiora, Michael S. Rafii, et al.
Nature Reviews Neurology (2022) Vol. 18, Iss. 7, pp. 389-399
Open Access | Times Cited: 86
Astrocyte biomarker signatures of amyloid-β and tau pathologies in Alzheimer’s disease
João Pedro Ferrari‐Souza, Pâmela C.L. Ferreira, Bruna Bellaver, et al.
Molecular Psychiatry (2022) Vol. 27, Iss. 11, pp. 4781-4789
Open Access | Times Cited: 85
Transgenic Mouse Models of Alzheimer’s Disease: An Integrative Analysis
Raquel Sánchez‐Varo, Marina Mejias‐Ortega, Juan José Fernandez-Valenzuela, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 10, pp. 5404-5404
Open Access | Times Cited: 79
Physiology and pharmacology of amyloid precursor protein
Yoonsuk Cho, Han‐Gyu Bae, Eitan Okun, et al.
Pharmacology & Therapeutics (2022) Vol. 235, pp. 108122-108122
Closed Access | Times Cited: 77
Helicobacter pylori‐derived outer membrane vesicles contribute to Alzheimer's disease pathogenesis via C3‐C3aR signalling
Junhua Xie, Lien Cools, Griet Van Imschoot, et al.
Journal of Extracellular Vesicles (2023) Vol. 12, Iss. 2
Open Access | Times Cited: 76
Page 1 - Next Page

Scroll to top